Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 0615-8560

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 0615-8560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acamprosate Calcium Structural Formula (Acamprosate Calcium Dr Tabs 8560 1)

Chemical structure of acamprosate calcium, showing the molecular arrangement including acetyl, amide, sulfonate groups and the calcium ion (Ca2+). This corresponds to the active ingredient in Acamprosate Calcium delayed-release tablets.*

FDA Label Image

Principal Display Panel (Acamprosate Calcium Dr Tabs 8560 2)

Label for Acamprosate Calcium delayed-release tablets 333 mg in a quantity of 30, manufactured by Mylan Limited and packaged by Vangard Labs. The label shows the NDC 0615-8560-39 and includes multiple barcodes, lot number 8560, storage instructions, and a note that it is for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.